A Multimodal Mind-Body Intervention for Fear of Recurrence among Cancer Survivors

NIH RePORTER · NIH · K23 · $157,367 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY This K23 career development award will position the candidate to become an independent clinical researcher with expertise in refining and testing mind-body interventions for managing fears of illness recurrence and associated healthcare engagement among medical patients. BACKGROUND. Fear of recurrence (FOR) is a common, highly distressing difficulty faced by individuals with a history of chronic and/or life-threatening illness. For example, cancer survivors, a growing population, report clinically-elevated FOR as a chief psychological concern. Notably, FOR may lead to worsened clinical outcomes, due to maladaptive healthcare engagement (e.g., avoidance or overuse of follow-up screenings). It is critical to develop evidence-based FOR interventions. Relaxation skills, mindfulness meditation, cognitive-behavioral skills, and positive psychology techniques are promising for reducing FOR in cancer survivors, yet trials have been limited by testing these skills in isolation and among homogenous samples (e.g., breast cancer only). SPECIFIC AIMS. The proposed studies employ mixed methods designs to: (1) refine a multimodal, mind-body intervention (Relaxation Response Resiliency Program) to target FOR among cancer survivors via tiered feedback from focus groups, individual interviews, and an interdisciplinary expert panel, (2) evaluate, in a pilot RCT, its feasibility and acceptability among cancer survivors with elevated FOR, and (3) explore within-group, longitudinal patterns of FOR, healthcare engagement, and their covariance across multiple timepoints. TRAINING. The candidate will achieve short- term goals through a resource-rich institutional environment and a cohesive training plan in (1) clinical trial design, (2) mixed methods and longitudinal data collection and analysis, and (3) evaluation of healthcare engagement. In addition to ongoing mentorship meetings and experiential training through the research plan, the candidate will complete targeted coursework, didactic trainings, and shadowing, present at local and national conferences, and publish in peer-reviewed journals. MENTORSHIP. The candidate will be supported by a stellar mentoring team: Elyse R. Park, PhD, MPD (primary mentor), Gloria Y. Yeh, MD, MPH (co-mentor), Conall O’Cleirigh, PhD (co-mentor), John Denninger, MD, PhD (consultant), Hang Lee, PhD (consultant), Jeffrey Peppercorn, MD, MPH (consultant), and Lynne Wagner, PhD (consultant). IMPACT. In line with NCCIH funding priorities, the proposed research will answer critical questions about (1) the feasibility and acceptability of mind-body approaches for hard-to-manage symptoms and (2) potential mechanisms underlying resiliency. While initial studies will focus on cancer survivors, it is anticipated that the candidate’s training and research will have broad applications to a variety of medical populations struggling with uncertainty about illness recurrence. Through this K23 award, the candidate will gain the training ...

Key facts

NIH application ID
10216182
Project number
5K23AT010157-03
Recipient
MASSACHUSETTS GENERAL HOSPITAL
Principal Investigator
Daniel Lee Hall
Activity code
K23
Funding institute
NIH
Fiscal year
2021
Award amount
$157,367
Award type
5
Project period
2019-08-15 → 2024-07-31